The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...
After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...
“We advise the pharmaceutical companies we work for to be transparent ... understand that if you invest heavily and therefore run a big risk, your profits will be higher than for people who ...